%PDF-1.4
%
74 0 obj
<>
endobj
71 0 obj
<>
endobj
147 0 obj
<>stream
Acrobat Distiller 4.05 for Macintosh
2004-09-13T14:05:12Z
2024-03-28T14:46:29-07:00
QuarkXPressª 4.11: AdobePS 8.8.0 (301)
2024-03-28T14:46:29-07:00
application/pdf
Heather
2003-830.oct
uuid:d25fd29b-1dd1-11b2-0a00-e908277d8900
uuid:d25fd29e-1dd1-11b2-0a00-d30000000000
endstream
endobj
60 0 obj
<>
endobj
61 0 obj
<>
endobj
75 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 40 0 R/Type/Page>>
endobj
1 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 42 0 R/Type/Page>>
endobj
4 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/Rotate 0/Thumb 44 0 R/Type/Page>>
endobj
12 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/Rotate 0/Thumb 46 0 R/Type/Page>>
endobj
20 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/Rotate 0/Thumb 48 0 R/Type/Page>>
endobj
28 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 50 0 R/Type/Page>>
endobj
31 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 52 0 R/Type/Page>>
endobj
34 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 54 0 R/Type/Page>>
endobj
177 0 obj
[181 0 R]
endobj
178 0 obj
<>stream
q
0 0 612 783 re
W n
BT
0.85091 0.85091 0.85091 rg
/T1_0 19 Tf
0.6283 0.7779 -0.7779 0.6283 8.2321 49.765 Tm
(Personal non-commercial use only. The Journal of Rheumatology. Copyright\
\251 2004. All rights reserved)Tj
ET
Q
1 g
/GS0 gs
0 783 m
0 783 l
f
q
-1 784 587 -785 re
W n
q
0 783.03 612 -783 re
W n
BT
0 0 0 1 k
/GS1 gs
/T1_1 1 Tf
-0.00011 Tc 0.02499 Tw 8 0 0 8 61 732.5293 Tm
[(cartilage, and bone in degenerative joint diseases. )54.8 (Arthritis Rheum)]TJ
0 Tc 0 Tw 0 -1.25 TD
(1993;36:1444-50.)Tj
-0.00011 Tc 0.02499 Tw -1.8 -1.25 Td
[(46.)-550.1 (Sauer SK, )54.8 (A)74 (verbeck B, Reeh PW)91.7 (. Denervation and NK1 receptor)]TJ
1.8 -1.25 Td
[(block modulate stimulated CGRP)-238.2 (and PGE)]TJ
0 Tc 0 Tw 5.2 0 0 5.2 200.129 699.8893 Tm
(2)Tj
-0.00011 Tc 0.02499 Tw 8 0 0 8 204.929 702.5293 Tm
(release from rat skin.)Tj
-17.9911 -1.25 Td
[(NeuroReport 2000;1)36.8 (1:283-6.)]TJ
-1.8 -1.25 Td
[(47.)-550.1 (Egg D. Concentrations of prostaglandin D)]TJ
0 Tc 0 Tw 5.2 0 0 5.2 197.0723 679.8893 Tm
(2)Tj
-0.00011 Tc 0.02499 Tw 8 0 0 8 199.6723 682.5293 Tm
(, E)Tj
0 Tc 0 Tw 5.2 0 0 5.2 208.759 679.8893 Tm
(2)Tj
0.02499 Tw 8 0 0 8 211.359 682.5293 Tm
(, F)Tj
-0.0002 Tc 0 Tw 5.2 0 0 5.2 220.0063 679.8893 Tm
(2a)Tj
-0.00011 Tc 0.02499 Tw 8 0 0 8 224.9142 682.5293 Tm
(, 6-keto-F)Tj
-0.0002 Tc 0 Tw 5.2 0 0 5.2 256.6592 679.8893 Tm
(1a)Tj
-0.00011 Tc 8 0 0 8 263.7671 682.5293 Tm
(and)Tj
0.02499 Tw -25.3459 -1.25 Td
(thromboxane B)Tj
0 Tc 0 Tw 5.2 0 0 5.2 110.7449 669.8893 Tm
(2)Tj
-0.00011 Tc 0.02499 Tw 8 0 0 8 115.5449 672.5293 Tm
(in synovial fluid from patients with inflammatory)Tj
-6.8181 -1.25 Td
(joint disorders and osteoarthritis. Z Rheumatol 1984;43:89-96.)Tj
-1.8 -1.25 Td
[(48.)-550.1 (Atik OS. Leukotriene B)]TJ
0 Tc 0 Tw 5.2 0 0 5.2 138.0258 649.8893 Tm
(4)Tj
-0.00011 Tc 0.02499 Tw 8 0 0 8 142.8258 652.5293 Tm
(and prostaglandin E)Tj
0 Tc 0 Tw 5.2 0 0 5.2 207.2063 649.8893 Tm
(2)Tj
-0.00011 Tc 0.02499 Tw 8 0 0 8 209.8063 652.5293 Tm
(-like activity in)Tj
-18.6008 -1.25 Td
(synovial fluid in osteoarthritis. Prostaglandins Leukot Essent Fatty)Tj
T*
(Acids 1990;39:253-4.)Tj
-1.8 -1.25 Td
[(49.)-550.1 (Amin )54.8 (AR, )54.8 (Attur M, Patel RN, et al. Superinduction of )]TJ
1.8 -1.25 Td
[(cyclooxygenase-2 activity in human osteoarthritis-af)17.7 (fected cartilage.)]TJ
T*
(J Clin Invest 1997;99:1231-7.)Tj
31.2 16.25 Td
[(50.)-550.1 (Gibson KT)73.9 (, Hodge H, )17.7 (Whittem )17.7 (T)74 (. Inflammatory mediators in equine)]TJ
1.8 -1.25 Td
[(synovial fluid. )54.8 (Aust )17.7 (V)110.8 (e)-0.1 (t 1996;73:148-51.)]TJ
-1.8 -1.25 Td
[(51.)-550.1 (Kirker)19.7 (-Head CA, Chandna )17.7 (VK, )54.8 (Agarwal RK, et al. Concentrations)]TJ
1.8 -1.25 Td
[(of substance P)-238.2 (and prostaglandin E)]TJ
0 Tc 0 Tw 5.2 0 0 5.2 437.8926 699.8893 Tm
(2)Tj
-0.00011 Tc 0.02499 Tw 8 0 0 8 442.6926 702.5293 Tm
(in synovial fluid of normal and)Tj
-14.7116 -1.25 Td
[(abnormal joints of horses. )54.8 (Am J )17.7 (V)110.8 (et Res 2000;61:714-8.)]TJ
-1.8 -1.25 Td
[(52.)-550.1 (Aley KO, Messing RO, Mochly-Rosen D, Levine JD. Chronic)]TJ
1.8 -1.25 Td
(hypersensitivity for inflammatory nociceptor sensitization mediated)Tj
T*
(by the epsilon isozyme of protein kinase C. J Neurosci)Tj
0 Tc 0 Tw T*
(2000;20:4680-5.)Tj
ET
0 0 0 1 K
43 72 m
547 72 l
S
BT
/T1_2 1 Tf
-0.00011 Tc 0.02499 Tw 8 0 0 8 409.3613 53.9844 Tm
(The Journal of Rheumatology 2004; 31:10)Tj
0 Tc 0 Tw -45.7952 -0.0313 Td
(2020)Tj
ET
0 0 0 0 k
/GS0 gs
97.25 77.25 396.47 -10.83 re
f*
0.5 w
97.25 77.25 396.47 -10.83 re
S
Q
Q
q
0 0 612 783 re
W n
BT
0 0 0 rg
/GS2 gs
/T1_3 8 Tf
110.368 69 Td
(Personal, non-commercial use only. The Journal of Rheumatology. Copyri\
ght \251 2004. All rights reserved.)Tj
ET
Q
BT
0 g
/GS2 gs
/T1_4 1 Tf
10 0 0 10 540 8 Tm
( )Tj
0 0.48627 0.77255 rg
/GS2 gs
-7.22298 0 Td
(www.jrheum.org)Tj
0 g
/GS2 gs
-16.72996 0 Td
(Downloaded on March 28, 2024 from )Tj
ET
endstream
endobj
54 0 obj
<>stream
8;Z\sJI[;T$q0RaJ$?\o#ebfuC5b3[jBgW]Un60?bf&h?I:B_&=eP]eS(gpm*k-jK
7:(%3M:+fX_J6:DL:\L"6(PADrN1r((/O]Meu;NrD=/lsc7F&**pQP629k2Cm[XZ'
d@!]:e0<7>=N2EZ+o6PjiF2mmU)-*NqI/cH274]3mUdA((^mHQKKV3UGlqonDC$+1
WSm=DV53ln4p(e&m(P^~>
endstream
endobj
58 0 obj
[/Indexed/DeviceRGB 255 57 0 R]
endobj
57 0 obj
<>stream
J,g]g+e/h_!_gCtO=0f)$P%cIi8Zdfc5&3j_8$7g.@L`YKUJNGBP\poR=_;Dl'P(T
(7Boo^^S:71(MN]ZQX/+Cbu.lK"p74pe1T%s.DY%&\1TdJhr54.M9au6>79n6`Q:4
PbLSZTLEE(8E@'*1mg_*eTnN*;*'V3+gm-EEetX%;Bo$ur2ss*N`.-!.kG_q6GDD'
dKoL!8Ka#EV,@V!\j8ZFbp6EE<9cn=N6j0nf;(&;QU6bUD')c@\
9-d\DA=cZ0Q>gIM$$;cd2O@&a;X,Nn_aP(]I1aRc(K1^ue>
gF/(+GaKo$qneLWDrQ#;5\S(\$q'4Q,85`-8;S(=Z"WSBOV*FM)4,?B],R
endstream
endobj
130 0 obj
<>
endobj
79 0 obj
<>
endobj
80 0 obj
<>
endobj
113 0 obj
<>
endobj
152 0 obj
<>
endobj
77 0 obj
<>
endobj
105 0 obj
<>stream
HU{PSg7$)kYTP\DER$<"/ ( FyP\_Z߈vDem.3E{nFt윙|sw~s~g}8fpw3la@*D*<>qYb< ftL-k-q֊:(GՏ֤gsE/hk
ÅO0ǩ3}2Y¤d o֬$}RD&慤ee%D>+e ĂK<ϓd'
ⳎDGxtD!lŧ'e>qvX(
Ec%0G6ֲ0?Jc,ÞcXeuf,K;ײhV4$~Jje[o04or:FQvv99|ecjaΑrr|TAڢ5J]l\:t}fXB
Vgȁp3WZ/hFҚuɕ
iaIQvVR'MTTYZnp!8tF OgȘa4vtdEl'g6W:H!HrMf7MpAGnP|3ђ':rk7ۮFfdɥgIq'Z}tO\\-ϸ^]m/)NŻ y5nFduTw?Wjԅ\ěSܥp`[ѥ>Y]T|ɜzÿh;Lv@-qGGk"*A$-jeUrmmOG7mwD"":"ƚ&a%ts`Ɋ"t8QH\T(|䗆J3B#IUR\R[t~;,\I먙 lm y
ֈ!x
,fG.攚s iM8Mt@=]f}wMߘMi(NTc^ZT(1]IyRdC8}j~#H8ڐ^ړpݟ-Ga`^u-r6:%r;s]6dv"9f6#Wv|[NtrZvlSO21.E9%&ݑv%^I:O9v{NL͠=U_;{]v0 5ORB9v}ɽ{D賧qOZ':LMF[RF>6
G )M-x=݂*X;z>;JtT/d.3Z<)3c.y EjCZɍ~83b"l*pAof,-`_Px;^f賰8`jMَG$Y:,]R^X/yTܫm<